Atracurium Besylate
NDC 55150-216, Atracurium Besylate, injection, solution, from AuroMedics Pharma LLC.
- Product NDC
- 55150-216
- Status
- Listed
- Labeler
- AuroMedics Pharma LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206010
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55150-216 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATRACURIUM BESYLATE50 mg/5mL
Pharmacologic classes
Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55150-216-05 | 55150021605 | 10 VIAL, SINGLE-USE in 1 CARTON (55150-216-05) / 5 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/71d4bc78-57df-474b-8b19-811a959f1fce
Use it
Look up 55150-216 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55150-216 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55150-216. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.